Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...

Coverage would include diagnostic testing to determine appropriate treatments, as well as prescribed treatments or ...

"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical ...